FEATURED TRIALS
Acute Migraine
A Study to Evaluate the Efficacy and Safety of BHV-2100 in Migraine
Drug: BHV-2100
Age: 18-64
Phase: 2
Generalized Epilepsy
Researching an Investigational Treatment Option for Idiopathic Generalized Epilepsy
Drug: BHV-7000
Age: 18-75
Phase: 3
FOCAL EPILEPSY
Researching an investigational treatment option for Focal Onset Epilepsy
Drug: BHV-7000
Age: 18-75
Phase: 2/3
Major Depressive Disorder
A Study to Evaluate the Efficacy and Safety of BHV-7000 Monotherapy in Major Depressive Disorder
Drug: BHV-7000
Age: 18-75
Phase: 2
Bipolar Disorder I
An Inpatient Study to Evaluate the Effectiveness and Safety of BHV-7000 for Manic Episodes Associated with Bipolar I Disorder
Drug: BHV-7000
Age: 18-75
Phase: 2/3
Obsessive Compulsive Disorder (OCD)
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Drug: Troriluzole
Age: 18-65
Phase: 3